Skip to main content
SpringerLink
Log in

Psycho-Neuro-Endocrine-Immunology: A Psychobiological Concept

  • Chapter
  • First Online:
Ultraviolet Light in Human Health, Diseases and Environment

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 996))

Abstract

Psycho-Neuro-Endocrine-Immunology (P.N.E.I.) is a scientific field of study that investigates the link between bidirectional communications among the nervous system, the endocrine system, and the immune system and the correlations of this cross-talk with physical health. The P.N.E.I. innovative medical approach represents a paradigm shift from a strictly biomedical view of health and disease taken as hermetically sealed compartments to a more interdisciplinary one. The key element of P.N.E.I. approach is represented by the concept of bidirectional cross-talk between the psychoneuroendocrine and immune systems. The Low Dose Medicine is one of the most promising approaches able to allow the researchers to design innovative therapeutic strategies for the treatment of skin diseases based on the rebalance of the immune response.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Commins SP, Borish L, Steinke JW (2010) Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol 125(2 suppl 2):S53–S72

    Article  PubMed  Google Scholar 

  2. Bacchus W, Aubel D, Fussenegger M (2013) Biomedically relevant circuit-design strategies in mammalian synthetic biology. Mol Syst Biol 9:691

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ader R, Cohen N (1993) Psychoneuroimmunology: conditioning and stress. Annu Rev Psychol 44:53–85

    Article  CAS  PubMed  Google Scholar 

  4. Ader R, Cohen N, Felten D (1995) Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet 345(8942):99–103

    Article  CAS  PubMed  Google Scholar 

  5. Ader R (1983) Developmental psychoneuroimmunology. Dev Psychobiol 16(4):251–267. (1 983)

    Article  CAS  PubMed  Google Scholar 

  6. Bottaccioli F, Carosella A, Cardone R, Mambelli M, Cemin M, D’Errico MM, Ponzio E et al (2014) Brief training of psychoneuroendocrinoimmunology-based meditation (PNEIMED) reduces stress symptom ratings and improves control on salivary cortisol secretion under basal and stimulated conditions. Explore (NY) 10(3):170–179

    Article  Google Scholar 

  7. Haroon E, Raison CL, Miller AH (2012) Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 37(1):137–162

    Article  CAS  PubMed  Google Scholar 

  8. Tojo R, Suárez A, Clemente MG (2014) De los Reyes-Gavilán CG, Margolles A, Gueimonde M, Ruas-Madiedo P. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol 20(41):15163–15176

    Article  PubMed  PubMed Central  Google Scholar 

  9. Myles IA, Williams KW, Reckhow JD, Jammeh ML, Pincus NB, Sastalla I, Saleem D et al (2016) Transplantation of human skin microbiota in models of atopic dermatitis. JCI Insight 1(10):pii: e86955

    Article  Google Scholar 

  10. O’Neill CA, Monteleone G, McLaughlin JT, Paus R (2016) The gut-skin axis in health and disease: a paradigm with therapeutic implications. BioEssays 38:1167–1176

    Article  PubMed  Google Scholar 

  11. Arck P, Handjiski B, Hagen E, Pincus M, Bruenahl C, Bienenstock J, Paus R (2010) Is there a ‘gut-brain-skin axis’? Exp Dermatol 19(5):401–405

    Article  PubMed  Google Scholar 

  12. Bowe WP, Logan AC (2011) Acne vulgaris, probiotics and the gut-brain-skin axis – back to the future? Gut Pathog 3(1):1

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kotas ME, Medzhitov R (2015) Homeostasis, inflammation, and disease susceptibility. Cell 160(5):816–827

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Hueston CM, Deak T (2014) The inflamed axis: the interaction between stress, hormones, and the expression of inflammatory-related genes within key structures comprising the hypothalamic-pituitaryadrenal axis. Physiol Behav 124:77–91

    Article  CAS  PubMed  Google Scholar 

  15. Khan MJ, Gerasimidis K, Edwards CA, Shaikh MG (2016) Role of gut microbiota in the aetiology of obesity: proposed mechanisms and review of the literature. J Obes 2016:7353642

    PubMed  PubMed Central  Google Scholar 

  16. Mancuso P (2016) The role of adipokines in chronic inflammation. Immunotargets Ther 5:47–56

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ganju P, Nagpal S, Mohammed MH, Nishal Kumar P, Pandey R, Natarajan VT, Mande SS et al (2016) Microbial community profiling shows dysbiosis in the lesional skin of Vitiligo subjects. Sci Rep 6:18761

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Turvey SE, Broide DH (2010) Innate immunity. J Allergy Clin Immunol 125(2 Suppl 2):S24–S32

    Article  PubMed  Google Scholar 

  19. Dainichi T, Hanakawa S, Kabashima K (2014) Classification of inflammatory skin diseases: a proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity. J Dermatol Sci 76(2):81–89

    Article  PubMed  Google Scholar 

  20. Rawles ME (1947) Origin of pigment cells from the neural crest in the mouseembryo. Physiol Zool 20:248–266

    Article  CAS  PubMed  Google Scholar 

  21. Hussain T, Tan B, Yin Y, Blachier F, Tossou MC, Rahu N (2016) Oxidative stress and inflammation: what polyphenols can do for us? Oxidative Med Cell Longev 2016:7432797

    Article  Google Scholar 

  22. Trifunović J, Miller L, Debeljak Ž, Horvat V (2015) Pathologic patterns of interleukin 10 expression--a review. Biochem Med (Zagreb) 25(1):36–48

    Article  Google Scholar 

  23. Deng Y, Chang C, Lu Q (2016) The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol 50(3):377–389

    Article  CAS  PubMed  Google Scholar 

  24. Zhen Y, Yao L, Zhong S, Song Y, Cui Y, Li S (2016) Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo. Arch Dermatol Res 308:703–710

    Article  CAS  PubMed  Google Scholar 

  25. Robert C, Kupper TS (1999) Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 341(24):1817–1828

    Article  CAS  PubMed  Google Scholar 

  26. van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P (2000) Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Investig 80(8):1299–1309

    Article  PubMed  Google Scholar 

  27. Marcum ZA, Hanlon JT (2010) Recognizing the risks of chronic nonsteroidal anti-inflammatory drug use in older adults. Ann Longterm Care 18(9):24–27

    PubMed  PubMed Central  Google Scholar 

  28. Dinarello CA (2003) Anti-cytokine therapeutics and infections. Vaccine 21(Suppl 2):S24–S34

    Article  PubMed  Google Scholar 

  29. Tessaro I, Modina SC, Franciosi F, Sivelli G, Terzaghi L, Lodde V et al (2015) Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome. J Ovarian Res 8(1):64

    Article  PubMed  PubMed Central  Google Scholar 

  30. Yun Y, Cho YW, Park K (2013) Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery. Adv Drug Deliv Rev 65(6):822–832

    Article  CAS  PubMed  Google Scholar 

  31. Burnett AF, Biju PG, Lui H, Hauer-Jensen M (2013) Oral interleukin 11 as a countermeasure to lethal total-body irradiation in a murine model. Radiat Res 180(6):595–602

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hanson ML, Hixon JA, Li W, Felber BK, Anver MR, Stewart CA et al (2014) Delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. Gastroenterology 146(1):210–221

    Article  CAS  PubMed  Google Scholar 

  33. Forster K, Goethel A, Chan CW, Zanello G, Streutker C, Croitoru K (2012) An oral CD3-specific antibody suppresses T-cell-induced colitis and alters cytokine responses to T-cell activation in mice. Gastroenterology 143(5):1298–1307

    Article  CAS  PubMed  Google Scholar 

  34. Renukuntla J, Vadlapudi AD, Patel A, Boddu SH, Mitra AK (2013) Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm 447(1–2):75–93

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH et al (2012) Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33(3):378–455

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Biancotto A, Wank A, Perl S, Cook W, Olnes MJ, Dagur PH et al (2013) Baseline levels and temporal stability of 27 multiplexed serum cytokine concentrations in healthy subjects. PLoS One 8(12):e76091

    Article  PubMed  PubMed Central  Google Scholar 

  37. Amendola A, Cerioli NL, Migliore L (2006) Ormesi: la rivoluzione dose-risposta. APAT, Roma

    Google Scholar 

  38. Stumpf WE (2006) The dose makes the medicine. Drug Discov Today 11(11/12):550–555

    Article  CAS  PubMed  Google Scholar 

  39. Hauss WH, Hulsing GJ, Gerlach U (1968) Die unspezifische Mesenchymreaktion Zur Pathogenese der reaktiven Mesenchymerkrankungen. Georg Thieme Verlag, Stuttgart, pp 29–35

    Google Scholar 

  40. Mattson MP, Calabrese EJ (2010) Hormesis a revolution in biology, toxicology and medicine. Springer, New York/Dordrecht/Heidelberg/London

    Google Scholar 

  41. VV AA (1994) Guideline for industry dose-response information to support drug registration. ICH. London

    Google Scholar 

  42. Olson HM, Kadyszewski E, Beierschmitt W (2001) Hormesis – a pharmaceutical industry perspective. Crit Rev Toxicol 31(4–5):659–661

    Article  CAS  PubMed  Google Scholar 

  43. Maynard KI (2011) Hormesis pervasiveness and its potential implications for pharmaceutical research and development. Dose-Response 9:377–386

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Krause CD, Pestka S (2005) Evolution of the class 2 cytokines and receptors, and discovery of new friends and relatives. Pharmacol Ther 106(3):299–346

    Article  CAS  PubMed  Google Scholar 

  45. Huising MO, Kruiswijk CP, Flik G (2006) Phylogeny and evolution of class-I helical cytokines. J Endocrinol 189(1):1–25

    Article  CAS  PubMed  Google Scholar 

  46. Wells JA (1996) Binding in the growth hormone receptor complex. Proc Natl Acad Sci U S A 93(1):1–6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813(5):878–888

    Article  CAS  PubMed  Google Scholar 

  48. Gariboldi S, Palazzo M, Zanobbio L, Dusio GF, Mauro V, Solimene U et al (2009) Low dose oral administration of cytokines for treatment of allergic asthma. Pulm Pharmacol Ther 22:497–510

    Article  CAS  PubMed  Google Scholar 

  49. D’Amico L, Ruffini E, Ferracini R, Roato I (2012) Low dose of IL-12 stimulates T cell response in cultures of PBMCs derived from non-small cell lung cancer patients. J Cancer Ther 3:337–342

    Article  Google Scholar 

  50. Cardani D, Dusio GF, Luchini P, Sciarabba M, Solimene U, Rumio C (2013) Oral Administration of Interleukin-10 and anti-IL-1 antibody ameliorates experimental intestinal inflammation. Gastroenterology Research 6:124–133

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Radice E, Miranda V, Bellone G (2014) Low-doses of sequential-kinetic-activated interferon-gamma enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study intern. Immunopharmacology 19:66–73

    Article  CAS  Google Scholar 

  52. Roberti ML, Ricottini L, Capponi A, Sclauzero E, Vicenti P, Fiorentini E et al (2014) Immunomodulating treatment with low dose interleukin-4, interleukin-10 and interleukin-11 in psoriasis vulgaris. J Biol Regul Homeost Agents 28:133–139

    CAS  PubMed  Google Scholar 

  53. Lotti T (2015) Successful combination treatment for psoriasis with phototherapy and low-dose cytokines: a spontaneous, retrospective observational clinical study. Hautarzt 66(11):849–854

    Article  CAS  PubMed  Google Scholar 

  54. Barygina V, Becatti M, Lotti T, Taddei N, Fiorillo C (2016) Low dose cytokines reduce oxidative stress in primary lesional fibroblasts obtained from psoriatic patients. J Dermatol Sci pii:S0923-1811(16)30119-0

    Google Scholar 

  55. Barygina V, Becatti M, Lotti T, Moretti S, Taddei N, Fiorillo C (2015) Treatment with low-dose cytokines reduces oxidative-mediated injury in perilesional keratinocytes from vitiligo skin. J Dermatol Sci 79(2):163–170

    Article  CAS  PubMed  Google Scholar 

  56. Lotti T, Hercogova J, Wollina U, Chokoeva AA, Zarrab Z, Gianfaldoni S et al (2015) Vitiligo: successful combination treatment based on oral low dose cytokines and different topical treatments. J Biol Regul Homeost Agents 29(1 Suppl):53–58

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centro Studi per la Ricerca Multidisciplinare e Rigenerativa, Universita Degli Studi “G. Marconi”, Rome, Italy

    Katlein França & Torello M. Lotti

  2. Institute for Bioethics & Health Policy; Department of Dermatology & Cutaneous Surgery; Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA

    Katlein França

Authors
  1. Katlein França
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Torello M. Lotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Torello M. Lotti .

Editor information

Editors and Affiliations

  1. Faculty of Science and Technology, Nottingham Trent University, Nottingham, United Kingdom

    Shamim I. Ahmad

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

França, K., Lotti, T.M. (2017). Psycho-Neuro-Endocrine-Immunology: A Psychobiological Concept. In: Ahmad, S. (eds) Ultraviolet Light in Human Health, Diseases and Environment. Advances in Experimental Medicine and Biology, vol 996. Springer, Cham. https://doi.org/10.1007/978-3-319-56017-5_11

Download citation

Publish with us

Policies and ethics

Search

Navigation